Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026)
Mineralys Therapeutics (MLYS) posted EPS (Basic) of -$0.55 for Q1 2026, up 79.94% sequentially from -$2.73 in Q4 2025, and up 34.53% YoY from -$0.41 in Q1 2025.
Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026) Analysis & Trends
Mineralys Therapeutics has reported EPS (Basic) for 5 years, with the latest figure at -$0.55 in Q1 2026.
- Quarterly EPS (Basic) rose 34.53% year-over-year to -$0.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.84 (up 27.52% YoY) and the FY2025 annual result came in at -$4.68, up 16.51% from the prior year.
- EPS (Basic) rose to -$0.55 in Q1 2026 per MLYS's latest filing, from -$2.73 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.4 in Q2 2023 and troughed at -$2.73 in Q4 2025.
- A 5-year average of -$1.15 and a median of -$0.84 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) jumped 68.52% in 2023, then tumbled 243.69% in 2024.
- Over 5 years, EPS (Basic) stood at -$1.97 in 2022, then jumped by 59.97% to -$0.79 in 2023, then slumped by 243.69% to -$2.71 in 2024, then slipped by 0.57% to -$2.73 in 2025, then jumped by 79.94% to -$0.55 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.55, -$2.73, and -$0.58 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Mineralys Therapeutics | 2.27 Bn | 1.60 Bn | - | -2.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.93 |
| Mar 31, 2026 | -0.55 |
| Dec 31, 2025 | -2.73 |
| Sep 30, 2025 | -0.58 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.84 |
| Dec 31, 2024 | -2.71 |
| Sep 30, 2024 | -1.21 |
| Jun 30, 2024 | -0.92 |
| Mar 31, 2024 | -0.79 |
| Dec 31, 2023 | -0.79 |
| Sep 30, 2023 | -0.66 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -1.97 |
| Sep 30, 2022 | -1.43 |
| Jun 30, 2022 | -1.26 |
| Mar 31, 2022 | -1.48 |